Click Here to return To Results

 

Efficacy of Idebenone on Respiratory Function in Patients with Duchenne Muscular Dystrophy not using Glucocorticoids (DELOS): A Double-Blind Randomised Placebo-Controlled Phase 3 Trial Lancet 385:1748-1757,1704, Buyse, G.M.,et al, 2015 See this aricle in Pubmed Article Abstract Idebenone reduced the loss of respiratory function and represents a new treatment option for patients with Duchenne muscular dystrophy.

Related Tags

(click to filter results - removes previous filter) advances in neurology efficacy idebenone muscular dystrophy muscular dystrophy,Duchenne pulmonary function tests respiratory failure safety treatment of neurologic disorder

Click Here to return To Results